Related references
Note: Only part of the references are listed.Design and validation of the first cell-impermeant melatonin receptor agonist
Florence Gbahou et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
Melatonin Synthesis: Acetylserotonin O-Methyltransferase (ASMT) Is Strongly Expressed in a Subpopulation of Pinealocytes in the Male Rat Pineal Gland
Martin F. Rath et al.
ENDOCRINOLOGY (2016)
Highly Potent and Selective MT2 Melatonin Receptor Full Agonists from Conformational Analysis of 1-Benzyl-2-acylaminomethyl-tetrahydroquinolines
Gilberto Spadoni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Understanding melatonin receptor pharmacology: Latest insights from mouse models, and their relevance to human disease
Gianluca Tosini et al.
BIOESSAYS (2014)
MT1 and MT2 Melatonin Receptors: Ligands, Models, Oligomers, and Therapeutic Potential
Darius P. Zlotos et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Melatonin enhances the human mesenchymal stem cells motility via melatonin receptor 2 coupling with Gαq in skin wound healing
Sei-Jung Lee et al.
JOURNAL OF PINEAL RESEARCH (2014)
Melatonin attenuates inflammatory response-induced brain edema in early brain injury following a subarachnoid hemorrhage: a possible role for the regulation of pro-inflammatory cytokines
Jingyin Chen et al.
JOURNAL OF PINEAL RESEARCH (2014)
The Timing of Timezyme Diversification in Vertebrates
Damien Cazamea-Catalan et al.
PLOS ONE (2014)
Molecular mechanisms of melatonin's inhibitory actions on breast cancers
Sara Proietti et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Homology Models of Melatonin Receptors: Challenges and Recent Advances
Daniele Pala et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Structure-Based Virtual Screening of MT2 Melatonin Receptor: Influence of Template Choice and Structural Refinement
Daniele Pala et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2013)
Investigational Selective Melatoninergic Ligands for Receptor Subtype MT2
Ning Wan et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2013)
Characterization of signaling pathways coupled to melatonin receptors in gastrointestinal smooth muscle
Rashad Ahmed et al.
REGULATORY PEPTIDES (2013)
Circadian Gating of Epithelial-to-Mesenchymal Transition in Breast Cancer Cells Via Melatonin-Regulation of GSK3β
Lulu Mao et al.
MOLECULAR ENDOCRINOLOGY (2012)
New Insights for Drug Design from the X-Ray Crystallographic Structures of G-Protein-Coupled Receptors
Kenneth A. Jacobson et al.
MOLECULAR PHARMACOLOGY (2012)
Signal transduction of receptor-mediated antiproliferative action of melatonin on human prostate epithelial cells involves dual activation of G alpha(s) and G alpha(q) proteins
Stephen Y. W. Shiu et al.
JOURNAL OF PINEAL RESEARCH (2010)
Homology modeling of MT1 and MT2 receptors
Amaury Farce et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2008)
Synthesis, enantiomeric resolution, and structure-activity relationship study of a series of 10,11-dihydro-5H-dibenzo[a,d]cycloheptene MT2 receptor antagonists
Gilberto Spadoni et al.
CHEMMEDCHEM (2007)
Assessment of the roles of serines 5.43(239) and 5.46(242) for binding and potency of agonist ligands at the human serotonin 5-HT2A receptor
Michael R. Braden et al.
MOLECULAR PHARMACOLOGY (2007)
Arylalkylamine N-acetyltransferase:: the timezyme
David C. Klein
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Differences in binding sites of two melatonin receptors help to explain their selectivity to some melatonin analogs: A molecular modeling study
Anton O. Chugunov et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2006)
Reassessing the melatonin pharmacophore-Enantiomeric resolution, pharmacological activity, structure analysis, and molecular modeling of a constrained chiral melatonin analogue
S Rivara et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
Ligand binding to the human MT2 melatonin receptor: The role of residues in transmembrane domains 3, 6, and 7
P Mazna et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Functional MT1 and MT2 melatonin receptors in mammals
ML Dubocovich et al.
ENDOCRINE (2005)
Analysis of structure-activity relationships for MT2 selective antagonists by melatonin MT1 and MT2 receptor models
S Rivara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Molecular modeling of human MT2 melatonin receptor: the role of Val204, Leu272 and Tyr298 in ligand binding
P Mazna et al.
JOURNAL OF NEUROCHEMISTRY (2004)
Mutagenesis studies of the human MT2 melatonin receptor
MJ Gerdin et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Important amino acids for the function of the human MT1 melatonin receptor
T Kokkola et al.
BIOCHEMICAL PHARMACOLOGY (2003)
Three-dimensional quantitative structure-activity relationship studies on selected MT1 and MT2 melatonin receptor ligands:: Requirements for subtype selectivity and intrinsic activity modulation
S Rivara et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Ocular hypotensive effects of melatonin receptor agonists in the rabbit:: further evidence for an MT3 receptor
J Pintor et al.
BRITISH JOURNAL OF PHARMACOLOGY (2003)
G protein-linked effector and second messenger systems involved in melatonin signal transduction
DC New et al.
NEUROSIGNALS (2003)
Constitutive activation of the opioid receptor-like (ORL1) receptor by mutation of Asn133 to tryptophan in the third transmembrane region
KWL Kam et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Molecular determinants for the differential coupling of G alpha(16) to the melatonin MT1, MT2 and Xenopus Mel1c receptors
FPL Lai et al.
JOURNAL OF NEUROCHEMISTRY (2002)
Gene expression of the key enzymes of melatonin synthesis in extrapineal tissues of the rat
J Stefulj et al.
JOURNAL OF PINEAL RESEARCH (2001)
Serine residues 110 and 114 are required for agonist binding but not antagonist binding to the melatonin MT1 receptor
S Conway et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Identification of the melatonin-binding site MT3 as the quinone reductase 2
O Nosjean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Chimeric melatonin mt1 and melatonin-related receptors -: Identification of domains and residues participating in ligand binding and receptor activation of the melatonin mt1 receptor
S Conway et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Melatonin limits transcriptional impact of phosphoCREB in the mouse SCN via the Mel1a receptor
C von Gall et al.
NEUROREPORT (2000)
Share Paper
